Chargement en cours...

Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression‐free survival: individual participant data analysis

BACKGROUND: Efficacy and the risk of severe late effects have to be well‐balanced in treatment of Hodgkin lymphoma (HL). Late adverse effects include secondary malignancies which often have a poor prognosis. To synthesise evidence on the risk of secondary malignancies after current treatment approac...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cochrane Database Syst Rev
Auteurs principaux: Franklin, Jeremy, Eichenauer, Dennis A., Becker, Ingrid, Monsef, Ina, Engert, Andreas
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd 2017
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483617/
https://ncbi.nlm.nih.gov/pubmed/28901021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008814.pub2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!